0001104659-24-004155.txt : 20240116 0001104659-24-004155.hdr.sgml : 20240116 20240116170342 ACCESSION NUMBER: 0001104659-24-004155 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240111 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saggar Rajeev CENTRAL INDEX KEY: 0001935638 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39724 FILM NUMBER: 24535866 MAIL ADDRESS: STREET 1: 419 DAVIS DRIVE STREET 2: SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Liquidia Corp CENTRAL INDEX KEY: 0001819576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851710962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 419 DAVIS DRIVE, SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919.328.4400 MAIL ADDRESS: STREET 1: 419 DAVIS DRIVE, SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 4 1 tm243427-5_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-11 0 0001819576 Liquidia Corp LQDA 0001935638 Saggar Rajeev 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 0 1 0 0 Chief Medical Officer 0 Common Stock 2024-01-11 4 A 0 56492 0 A 220591 D Performance Stock Units 2024-01-11 4 A 0 56492 0 A Common Stock 56492 56492 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs shall vest on January 11, 2025 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. Includes (i) 46,052 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023 and (iii) 1,189 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. On January 11, 2024, the Reporting Person was granted 56,492 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. /s/ Dr. Rajeev Saggar 2024-01-16